A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Clarius PA HD Handheld Ultrasound Scanner Available for Rapid Bedside Cardiac Exams: Offers Clear Cardiac Ultrasound Imaging & Fast Frame Rates

November 25, 2020

Clarius PA HD is now available for high-resolution cardiac imaging with the release of the Clarius Ultrasound App 7.3.0, available for download on the Apple App Store and Google Play.

Clarius PA HD is the only wireless handheld scanner that offers clear cardiac ultrasound imaging and fast frame rates comparable to traditional hospital ultrasound systems, made possible by advanced 8 beamformer processing. Designed for cardiac and lung imaging, it enables physicians to access the power of high-definition imaging using most iOS and Android smartphones and tablets.

Dr. Zachary Laksman, MD, MSc, Cardiologist and Heart Rhythm Specialist working in a busy academic center says that the demand for handheld ultrasound scanners has been highlighted during the global pandemic: “Portable bedside imaging has become an incredibly important part of my Cardiology and Cardiac Electrophysiology practice. I have increasingly relied on my wireless Clarius scanner both in my office practice, on the hospital wards, and in the peri-operative unit.”

This year, the American Society of Echocardiography also recognized the value and prevalence of POCUS. In the ASE Statement on Point-of-Care Ultrasound during the 2019 Novel Coronavirus Pandemic, the Society notes “the rapid, bedside assessment of the heart, chest, and vessels using point-of-care ultrasound (POCUS) has propelled this tool to the front lines of the fight against the COVID-19 pandemic. POCUS is usually conducted by the treating provider to obtain real-time information for management decisions.”

“I have been exceedingly impressed with the Clarius Phased Array Scanner and had the opportunity to trial the most recent software update (7.3). The image quality has always been truly outstanding, and now the platform is more intuitive and responsive,” reports Dr. Laksman. “From trainee and patient education to acute and chronic care settings, including peri-operative patient management, the Clarius scanner has exceeded expectations and provided new opportunities to improve care under the most difficult circumstances.”

In addition to excellent cardiac and lung imaging, the Clarius PA HD is suitable for FAST exams, superficial and transcranial imaging. Its no-subscription pricing includes unlimited cloud storage and image management for unlimited users, a 3-year warranty, and forever-free software updates.

“Since the start of the pandemic, more physicians than ever are using handheld scanners for cardiac and lung exams because they are simple to carry from one isolated room to another. Our wireless scanners have the added advantage that they are easy to disinfect,” says Clarius CEO Laurent Pelissier. “Our goal is to equip cardiac specialists with a handheld system that will serve them well during the pandemic and beyond by providing outstanding image quality in a compact form without wires.”

Reimbursements for cardiac exams using ultrasound are available in the United States to help offset the cost of ultrasound systems. Plans vary by state and provider. A guide to reimbursements is available here.

To support billing and reports, Clarius scanners come with free access to the HIPPA-compliant Clarius Cloud, which has a built-in, customizable PDF tool, making it easy to print, archive and share professional reports. Users save images on their device or the Cloud. An option to connect to any DICOM-compliant server is also available.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy